SSG
TMO icon

Summit Securities Group’s Thermo Fisher Scientific TMO Stock Holding History

Summit Securities Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.1K Buy
86
+24
+39% +$11.5K ﹤0.01% 606
2026
Q1 		$30.5K Sell
62
-495
-89% -$269K ﹤0.01% 457
2025
Q4 		$323K Sell
557
-93
-14% -$52.6K 0.04% 252
2025
Q3 		$315K Sell
650
-216
-25% -$101K 0.07% 216
2025
Q2 		$351K Buy
+866
New +$362K 0.07% 166
2023
Q3 		– Sell
-504
Closed -$263K – 1009
2023
Q2 		$263K Sell
504
-266
-35% -$144K 0.03% 191
2023
Q1 		$444K Buy
770
+370
+93% +$209K 0.04% 147
2022
Q4 		$220K Buy
400
+157
+65% +$83.2K 0.01% 463
2022
Q3 		$123K Sell
243
-573
-70% -$321K 0.01% 491
2022
Q2 		$443K Buy
816
+655
+407% +$361K 0.06% 198
2022
Q1 		$95K Buy
+161
New +$92.5K 0.01% 519
2015
Q3 		– Sell
-378
Closed -$49K – 514
2015
Q2 		$49K Buy
+378
New +$49.3K 0.02% 201

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Summit Securities Group's TMO Position: Q2 2026 in Review

Summit Securities Group increased its Thermo Fisher Scientific (TMO) stake by 39% in Q2 2026, buying an estimated $11.5K and bringing the position to 86 shares worth $43.1K. The position accounts for ﹤0.01% of the portfolio, ranked #606.

Summit Securities Group first reported a position in TMO in Q2 2015 and has held it in 12 quarters since. The position peaked at $444K in Q1 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Summit Securities Group held 86 shares of Thermo Fisher Scientific worth $43.1K as of Q2 2026.
  • Summit Securities Group bought 24 Thermo Fisher Scientific shares in Q2 2026, an estimated $11.5K.
  • Thermo Fisher Scientific made up ﹤0.01% of Summit Securities Group's portfolio in Q2 2026, its #606 holding.
  • Summit Securities Group first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 12 quarters since.
  • Summit Securities Group's Thermo Fisher Scientific position peaked at $444K in Q1 2023.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.